Form 4: Amprius Director Kang Sun Sells Shares
Insider Transaction Report
Amprius Technologies Director Kang Sun exercised stock options and subsequently sold over 500,000 shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- Kang Sun, a Director of Amprius Technologies, Inc., executed multiple transactions on January 12, 2026.
- Exercised stock options to acquire 180,802 shares at $0.62, 208,264 shares at $2.44, and 117,201 shares at $2.50.
- Sold 506,267 shares of common stock at an average price of $10.0964, with prices ranging from $10.00 to $10.25.
- All transactions were conducted under a Rule 10b5-1 trading plan adopted on August 18, 2025.
- Following these transactions, Kang Sun directly beneficially owns 1,403,651 shares, which includes 1,285,576 restricted stock units.
- An additional 274,275 shares are indirectly held by the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST.
Sentiment
Score: 4
Explanation: The sale of a significant number of shares by a director, even under a 10b5-1 plan, can be perceived as a slight negative by the market, though the pre-scheduled nature mitigates some of the concern. The director still retains substantial holdings.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned sale rather than a reaction to new, negative information.
- The director still retains a significant beneficial ownership of 1,403,651 direct shares (including RSUs) and 274,275 indirect shares.
Negatives
- A director selling a substantial number of shares (506,267) could be perceived negatively by investors, potentially signaling a desire for diversification or liquidity rather than strong future confidence.
Future Outlook
NA
Industry Context
This filing is specific to an individual director's stock transactions and does not provide broader industry context or trends.
Related Party Transactions
- 274,275 shares are indirectly held by the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST, for which the reporting person and his spouse are co-trustees.
Stakeholder Impact
- Shareholders: The sale by a director could lead to a perception of reduced insider confidence, potentially influencing short-term stock price movements. However, the 10b5-1 plan context suggests a pre-planned diversification or liquidity event rather than a reaction to new company-specific news.
- Employees, Customers, Suppliers, Creditors: Unlikely to have a direct impact from an individual director's stock transaction.
Key Dates
| Date | Description |
|---|---|
| 2022-09-14 | Date exercisable for stock option with exercise price $0.62. |
| 2024-10-23 | Date exercisable for stock options with exercise prices $2.44 and $2.50. |
| 2025-08-18 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 2026-01-12 | Date of stock option exercises and common stock sale transactions. |
| 2026-01-14 | Date the Form 4 was signed. |
| 2027-12-12 | Expiration date for stock option with exercise price $0.62. |
| 2029-01-02 | Expiration date for stock option with exercise price $2.44. |
| 2030-09-17 | Expiration date for stock option with exercise price $2.50. |
Recommendation
holdWhile the sale of shares by a director can sometimes signal a lack of confidence, the execution under a Rule 10b5-1 plan suggests a pre-planned financial event rather than a reaction to new, negative company information. The director still retains a substantial number of shares and RSUs. Without additional company-specific news, this transaction alone does not warrant a change from a 'hold' position, but it should be monitored in conjunction with other company developments.
Keywords
Amprius Technologies, AMPX, Kang Sun, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Director Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.